The Effectiveness of Unified Protocol for Transdiagnostic Treatment on people with Separation Anxiety Disorder

The Effectiveness of Unified Protocol for Transdiagnostic Treatment on Symptoms and Emotional and Cognitive indices of Adults with Separation Anxiety Disorder Comorbid with Emotional Disorders: A Randomized Controlled Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240227061119N1

Enrollment

Registered

2024-07-23

Start date

2024-07-10

Completion date

Unknown

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult separation anxiety disorder.

Interventions

Intervention 1: Intervention group: UP group. Unified protocol for transdiagnostic of emotional disorders consists of a maximum of 10, 45-minute individual treatment sessions. The UP targets and regul

identifying emotion-driven behaviors (EDBs) and replacing them with adaptive behaviors

identifying and preventing patterns of emotion avoidance

increasing awareness and confronting physical sensations, and facing emotions in situations. The treatment is preceded by enhancing the motivation and readiness of individuals for change and treatment

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Having the diagnostic criteria DSM-5-TR for separation anxiety disorder and comorbid emotional disorders, and not taking drugs related to disorder. Consent to participate in the research Being at least 18 years old Having at least a diploma Not receiving any type of treatment related to the disorder during the past year Speak Persian fluently Ability to participate in all assessment and treatment sessions

Exclusion criteria

Exclusion criteria: Receiving any other type of psychological treatment Having any type of personality disorder and diagnosing any type of psychiatric disorder (except for emotional disorders) Substance abuse Having serious thoughts about Suicide Taking medications related to disorders

Design outcomes

Primary

Measure	Time frame
Separation anxiety score in adult separation anxiety questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Adult Separation Anxiety Questionnaire (ASA-27).;Cognitive fusion score in cognitive fusion questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Cognitive fusion Questionnaire (CFQ).;Anxiety sensitivity score in anxiety sensitivity questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Anxiety Sensitivity Questionnaire (ASI).;Intolerance of uncertainty score in intolerance of uncertainty questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Intolerance Uncertainty Questionnaire (IUS).;Emotion regulation score in the emotion regulation difficulty scale. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Difficulties Emotion Regulation scale (DERS).;Anxiety score in dass21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Dass21 questionnaire.;Depression score in dass21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Dass21 questionnaire.	—

Measure

Time frame

Separation anxiety score in adult separation anxiety questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Adult Separation Anxiety Questionnaire (ASA-27).;Cognitive fusion score in cognitive fusion questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Cognitive fusion Questionnaire (CFQ).;Anxiety sensitivity score in anxiety sensitivity questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Anxiety Sensitivity Questionnaire (ASI).;Intolerance of uncertainty score in intolerance of uncertainty questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Intolerance Uncertainty Questionnaire (IUS).;Emotion regulation score in the emotion regulation difficulty scale. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Difficulties Emotion Regulation scale (DERS).;Anxiety score in dass21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Dass21 questionnaire.;Depression score in dass21 questionnaire. Timepoint: Pre-treatment; post-treatment; follow-up. Method of measurement: Dass21 questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeideh Sobhani

The University of Kurdestan

saeideh.sobhani@uok.ac.ir+98 31 4261 7092

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026